Nina Stevanović is a Research Associate in the Group for Rare Disease Research and Therapeutics Development in IMGGE. She is a PhD candidate in the Molecular Biomedicine program at the Faculty of Biology, University of Belgrade. Her research focuses on elucidating the molecular mechanisms underlying rare pulmonary diseases, with a particular emphasis on primary ciliary dyskinesia.

Her doctoral research is centered on the development and application of advanced in vitro models of human respiratory epithelium, based on the differentiation of primary human bronchial epithelial cells under air–liquid interface conditions. Through these models, she investigates the regulatory networks governing ciliogenesis, epithelial cell fate specification, and the balance between multiciliated and secretory (goblet) cell differentiation, with a particular focus on microRNA-mediated regulation.

Her experimental framework integrates gene expression profiling of key ciliogenesis regulators with high-resolution phenotypic characterization using immunofluorescence and confocal microscopy. A central aspect of her work is the identification of novel therapeutic strategies through targeted modulation of molecular pathways and the evaluation of small-molecule interventions.

She is actively engaged in the molecular genetic diagnostics of rare diseases at the Center for Rare Disease Diagnostics at IMGGE.

She holds a degree in Molecular Biology and Physiology and a Master’s degree in Human Genetics from the Faculty of Biology, University of Belgrade. Her Master’s thesis, entitled “Molecular characterization of newly identified genetic variants in patients with primary ciliary dyskinesia,” laid the foundation for her current research interests. Since 2020, she has been affiliated with IMGGE, contributing to national and international research initiatives in the field of rare diseases.